Open AccessThe clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital
Author(s) -
Kingbherly L Li,
Cybéle Lara R. Abad
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.01.022
Subject(s) - colistin , medicine , acinetobacter baumannii , ventilator associated pneumonia , pneumonia , meropenem , septic shock , carbapenem , nephrotoxicity , retrospective cohort study , antibiotics , sepsis , surgery , pseudomonas aeruginosa , antibiotic resistance , toxicity , microbiology and biotechnology , bacteria , biology , genetics
Colistimethate sodium (colistin) is used to treat multidrug-resistant gram negative infections. We describe the profile and outcomes of patients given colistin in a tertiary level government hospital in Manila, Philippines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom